Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 3/2011

01-03-2011 | Original Paper

Isolation and comparison of mesenchymal stem-like cells from human gastric cancer and adjacent non-cancerous tissues

Authors: Xiaomeng Xu, Xu Zhang, Sheng Wang, Hui Qian, Wei Zhu, Huiling Cao, Mei Wang, Yuan Chen, Wenrong Xu

Published in: Journal of Cancer Research and Clinical Oncology | Issue 3/2011

Login to get access

Abstract

Purpose

Mesenchymal stem cell (MSC)-like cells, a subpopulation of tumor microenvironment, have been isolated from several tumor tissues. In our previous study, we identified MSC-like cells in human gastric cancer tissues and found their characteristics to be similar to those of bone marrow MSCs. However, whether there are MSC-like cells in adjacent non-cancerous tissues and any difference between the MSC-like cells derived from tumor and non-cancerous tissues are not clear. The aim of this study is to study and research the differences of two mesenchymal stem-like cells.

Methods

We demonstrate that MSC-like cells can be isolated from both human gastric tumor (hGC-MSCs) and adjacent non-cancerous tissues (hGCN-MSCs) of the same patient. We further compared the characteristics between hGC-MSCs and hGCN-MSCs.

Results

Our results revealed that hGC-MSCs and hGCN-MSCs possessed similar morphological properties; stem cell-associated gene expression, as well as multipotential differentiation capability. We also found differences in cell surface markers, pluripotency, and proliferation-related gene expression between hGCN-MSCs and hGC-MSCs.

Conclusions

Our findings suggest that MSC-like cells are components of the tumor microenvironment and provide proof for the origin of carcinoma-associated fibroblast, therefore may potentially be used as a target for gastric cancer diagnosis and therapy.
Literature
go back to reference Bjerkvig R, Tysnes BB, Aboody KS, Najbauer J, Terzis AJ (2005) Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat Rev Cancer 5(11):899–904. doi:10.1038/nrc1740 CrossRefPubMed Bjerkvig R, Tysnes BB, Aboody KS, Najbauer J, Terzis AJ (2005) Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat Rev Cancer 5(11):899–904. doi:10.​1038/​nrc1740 CrossRefPubMed
go back to reference Liu Y, Hu T, Shen J, Li SF, Lin JW, Zheng XH et al (2006) Separation, cultivation and biological characteristics of oral carcinoma-associated fibroblasts. Oral Dis 12(4):375–380CrossRefPubMed Liu Y, Hu T, Shen J, Li SF, Lin JW, Zheng XH et al (2006) Separation, cultivation and biological characteristics of oral carcinoma-associated fibroblasts. Oral Dis 12(4):375–380CrossRefPubMed
go back to reference Zhu H, Mitsuhashi N, Klein A, Barsky LW, Weinberg K, Barr ML et al (2005) The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix. Stem Cells 24(4):928–935. Epub Nov 23. doi:10.1634/stemcells.2005-0186 Zhu H, Mitsuhashi N, Klein A, Barsky LW, Weinberg K, Barr ML et al (2005) The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix. Stem Cells 24(4):928–935. Epub Nov 23. doi:10.​1634/​stemcells.​2005-0186
Metadata
Title
Isolation and comparison of mesenchymal stem-like cells from human gastric cancer and adjacent non-cancerous tissues
Authors
Xiaomeng Xu
Xu Zhang
Sheng Wang
Hui Qian
Wei Zhu
Huiling Cao
Mei Wang
Yuan Chen
Wenrong Xu
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 3/2011
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-010-0908-6

Other articles of this Issue 3/2011

Journal of Cancer Research and Clinical Oncology 3/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.